Healthcare & life sciences presentation design

Yes. Every presentation we build for pharmaceutical clients is engineered with Medical, Legal, and Regulatory review in mind from the first slide. We build annotation layers, reference footnotes, and claim boundaries into the template architecture - so content moves through MLR review in fewer cycles, not more.

Yes. MSL and Medical Affairs deck design is one of our core life sciences services. We build modular, MLR-compliant MSL decks - KOL meeting decks, compendium slides, disease state overviews, and congress data summaries - delivered overnight so your team has what they need for the next morning's meeting.

Yes, always. We do not impose our own visual system. We work within your approved template, your brand standards, and your MLR formatting requirements. If your template has specific footnote zones, reference numbering conventions, or fair balance layout requirements, we build within those constraints from the first slide.

Yes. A significant portion of our life sciences work comes from strategy consultancies building presentations for pharma and biotech clients - pipeline strategy, competitive landscape analysis, market access modelling, and launch readiness. We work as a white-label visual engineering partner: the consultancy maintains the client relationship, we produce the presentation to the standard the client expects.

Yes. For teams with consistent monthly production volume - MSL deck updates, payer submission materials, KOL meeting preparation, congress data summaries - we offer fixed-cost retainer arrangements. A retainer eliminates per-project negotiation, provides dedicated account management, and ensures the same team handles your work with accumulated context about your assets and brand standards.

Yes, and accuracy is non-negotiable. We reproduce clinical data visuals exactly as they appear in the source publication - no extrapolation, no axis manipulation, no selective emphasis that misrepresents the data. We understand that a Forest plot reproduced incorrectly is not a design error - it is a compliance and scientific integrity failure.

We cover the full range of life sciences communication: MSL and Medical Affairs decks, HEOR and payer engagement presentations, biotech investor decks, clinical data readout presentations, KOL advisory board materials, congress posters and symposium slides, market access submissions, internal launch readiness decks, and scientific exchange materials for pharma BD teams.

Yes. We work with HEOR and market access teams building submissions for NICE, HTA bodies, and formulary committees. We understand that a payer presentation is not a clinical deck - it needs to lead with cost-effectiveness logic, present outcomes data in committee-readable formats, and make the value argument in the time a formulary reviewer has available.

Two things. First, Vaidehi Shukla - our Principal of Life Sciences and Market Research - reviews every life sciences engagement for scientific accuracy, MLR compliance risk, and investor or payer narrative logic. No generalist design agency has that. Second, we have built presentation materials for pharmaceutical clients including Abbott and Glenmark, and for life sciences strategy specialists including Prescient Healthcare Group. We understand the claim sensitivity, annotation conventions, and visual standards that your internal reviewers expect - because we have worked within them.

Yes. We design Seed, Series A, and Series B biotech investor decks - translating clinical pipeline data, mechanism of action, and regulatory strategy into investment narratives that generalist investors can follow and specialist reviewers can trust. We understand what biotech VCs and pharma BD teams evaluate, and we build the visual architecture around that evaluation logic.

Every engagement begins with an NDA before a single slide is shared with us. Unpublished trial data, competitive pipeline intelligence, and partnering strategy are held in a ring-fenced project environment. Materials are never shared across clients and are not retained beyond the agreed project period.

Our standard production window is 24 hours. You send us source materials at close of business - a draft deck, published data, raw clinical outputs, or a brief - and we return a formatted, presentation-ready file by 8:00 AM the following morning. For JP Morgan, ASCO, EHA, and other conference deadlines, overnight production is specifically what we are built for.

Three steps. First, you send us your source materials - existing deck, brief, published data, brand guidelines, and any MLR or formatting constraints. Second, our team structures and formats the presentation overnight, flagging any content that may carry MLR risk. Third, you receive an editable PowerPoint file the following morning. Revisions based on internal review are turned around the same business day.

Yes. Our data handling practices are GDPR-compliant. Client data is processed and stored in accordance with applicable data protection requirements. Specific data handling terms can be agreed as part of the engagement contract for clients with stringent data governance requirements.

Email us at info@a1slides.com with a brief description of the presentation you need, your timeline, and any source materials you can share. We will respond within two hours during business hours with a confirmation and next steps. For urgent overnight requests, include "OVERNIGHT" in the subject line.